» Articles » PMID: 24706040

Exacerbation-like Respiratory Symptoms in Individuals Without Chronic Obstructive Pulmonary Disease: Results from a Population-based Study

Overview
Journal Thorax
Date 2014 Apr 8
PMID 24706040
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Exacerbations of COPD are defined clinically by worsening of chronic respiratory symptoms. Chronic respiratory symptoms are common in the general population. There are no data on the frequency of exacerbation-like events in individuals without spirometric evidence of COPD.

Aims: To determine the occurrence of 'exacerbation-like' events in individuals without airflow limitation, their associated risk factors, healthcare utilisation and social impacts.

Method: We analysed the cross-sectional data from 5176 people aged 40 years and older who participated in a multisite, population-based study on lung health. The study cohort was stratified into spirometrically defined COPD (post-bronchodilator FEV1/FVC < 0.7) and non-COPD (post bronchodilator FEV1/FVC ≥ 0.7 and without self-reported doctor diagnosis of airway diseases) subgroups and then into those with and without respiratory 'exacerbation-like' events in the past year.

Results: Individuals without COPD had half the frequency of 'exacerbation-like' events compared with those with COPD. In the non-COPD group, the independent associations with 'exacerbations' included female gender, presence of wheezing, the use of respiratory medications and self-perceived poor health. In the non-COPD group, those with exacerbations were more likely than those without exacerbations to have poorer health-related quality of life (12-item Short-Form Health Survey), miss social activities (58.5% vs 18.8%), miss work for income (41.5% vs 17.3%) and miss housework (55.6% vs 16.5%), p<0.01 to <0.0001.

Conclusions: Events similar to exacerbations of COPD can occur in individuals without COPD or asthma and are associated with significant health and socioeconomic outcomes. They increase the respiratory burden in the community and may contribute to the false-positive diagnosis of asthma or COPD.

Citing Articles

Functionally important respiratory symptoms and continued cigarette use versus e-cigarette switching: population assessment of tobacco and health study waves 2-6.

Sargent J, Lauten K, Edwards K, Tanski S, MacKenzie T, Paulin L EClinicalMedicine. 2025; 79:102951.

PMID: 39968205 PMC: 11833018. DOI: 10.1016/j.eclinm.2024.102951.


Self-report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study.

Abrham Y, Zeng S, Lin W, Lo C, Beckert A, Evans L BMC Pulm Med. 2024; 24(1):433.

PMID: 39223571 PMC: 11367895. DOI: 10.1186/s12890-024-03239-8.


COPD after "Tabouna" Exposure: A Distinct Phenotype in Tunisian Women?.

Hamdi B, Louhaichi S, Jebali M, Schlemmer F, Maitre B, Hamzaoui A J Clin Med. 2023; 12(23).

PMID: 38068475 PMC: 10707064. DOI: 10.3390/jcm12237424.


Understanding Early COPD.

Lee B, Han M Respir Care. 2023; 68(7):881-888.

PMID: 37353336 PMC: 10289618. DOI: 10.4187/respcare.10612.


Clinical features and 1-year outcomes of chronic bronchitis in participants with normal spirometry: results from the ECOPD study in China.

Wu F, Zheng Y, Zhao N, Peng J, Deng Z, Yang H BMJ Open Respir Res. 2023; 10(1).

PMID: 37028909 PMC: 10083876. DOI: 10.1136/bmjresp-2022-001449.


References
1.
Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R . Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363(12):1128-38. DOI: 10.1056/NEJMoa0909883. View

2.
Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

3.
Kanner R, Anthonisen N, Connett J . Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001; 164(3):358-64. DOI: 10.1164/ajrccm.164.3.2010017. View

4.
Mallia P, Message S, Gielen V, Contoli M, Gray K, Kebadze T . Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med. 2010; 183(6):734-42. PMC: 3081284. DOI: 10.1164/rccm.201006-0833OC. View

5.
Montes de Oca M, Halbert R, Lopez M, Perez-Padilla R, Talamo C, Moreno D . The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J. 2012; 40(1):28-36. DOI: 10.1183/09031936.00141611. View